84th Annual General Meeting of Galenica Ltd.: Shareholders approve all proposals submitted by the Board of Directors
Thursday, 3 May 2012, ↓ directly to download
At the 84th Annual General Meeting of Galenica Ltd., the shareholders approved all the proposals submitted by the Board of Directors. Fritz Hirsbrunner was elected to the Board of Directors for a three-year period of office. The remuneration report was also approved by nearly 90% of the votes.
_The 84th Annual General Meeting of Galenica Ltd. held today in Bern was attended by 348 shareholders representing in total 77.3% of the registered voting shares of Galenica Ltd.
_The shareholders supported the proposals of the Board of Directors on all items on the agenda: The Annual General Meeting approved the Annual Reports and the Financial Statements for 2011 for Galenica Ltd. and the Galenica Group and gave discharge to the members of the Board and the Corporate Executive Committee for the financial year 2011. The remuneration report, which was submitted for an advisory vote to the shareholders for the fifth time, was also approved by nearly 90% of the votes.
_Paul Fasel, a member of the Board of Directors for 15 years, decided not to stand for re-election. As Vice Chairman, Lead Director and a certified pharmacist, Paul Fasel rendered great service to the company during his period of office: he was intimately involved in the transformation of the Galenica Group from a company owned by pharmacists into the modern enterprise Galenica is today.
_Daniela Bosshardt-Hengartner and Stefano Pessina were each re-elected for a further three-year period of office.
Fritz Hirsbrunner was elected as a new member of the Board of Directors for a period of office of three years.
_Furthermore, the shareholders approved amendments to the Articles of Incorporation. These amendments were necessary to extend the period during which the authorised share capital can be increased, and in order to comply with various changes in the law.
_The dividend of CHF 9.00 (+12.5%, prior year: CHF 8.00) proposed by the Board was also approved and will be paid to the shareholders on 10 May 2012.
_The next Annual General Meeting of Galenica Ltd. will take place on 2 May 2013.
Galenica is a diversified Group active throughout the healthcare market which, among other activities, develops, manufactures and markets pharmaceutical products, runs pharmacies, provides logistical and database services and sets up networks. With its two Business units Vifor Pharma and Galenica Santé, the Galenica Group enjoys a leading position in all its core business activities. A large part of the Group’s income is generated by international operations. Galenica is listed on the Swiss Stock Exchange (SIX Swiss Exchange, GALN, security number 1,553,646).
Thursday, 20 December 2012
Friday, 9 November 2012
Tuesday, 14 August 2012
Thursday, 26 July 2012
Head of Corporate Communications